1204 Whiskey Rd, Suite B
Up & Atom Breakfasts
Citizens for Nuclear Technology Awareness Presents:
Mr. Eric Nygaard
B&W's mPower Program
Topic: B&W Reactor Development Programs: mPower and MIPS
Wednesday, May 7th, 2014
117 Newberry St, Aiken SC
The Babcock & Wilcox Company sponsors two major development programs to service future energy and medical needs. Eric will provide an update of recent progress and strategic direction.
The Generation mPower initiative is the first advanced, inherently safe, technology for Small Modular Reactors (SMR) to have an operational, design-specific test facility. B&W is working with its stakeholders to find the most efficient way to move the technology toward licensing and deployment in the mid-2020 timeframe.
The Medical Isotope Production System (MIPS) would build on the modular concept to provide new production capacity for molybdenum-99, the precursor of the medically important radioisotope technetium-99m. The United States does not currently have the capability to produce this critical isotope and production has been sporadic in the rest of the world. MIPS would use low-enriched uranium, a significant improvement over the highly enriched uranium that has been used traditionally for medical isotopes but is being phased out internationally.